Andrija Tomovic is Oncology General Manager for Bulgaria (BG) and North Macedonia (NM) at Novartis since 2021Q1 and Novartis Group Bulgaria Country President a.i. since June’21. Before joining the Novartis BG & NM team Andrija held various cross-functional positions of increasing responsibilities within Novartis in Rotkreuz (Switzerland) – Swiss Oncology Business Unit, Origgio/Milan (Italy) – Oncology Region Europe, Basel (Switzerland) – Novartis Research and Development organizations, including Novartis Corporate, Group Finance / Investor Relations also in Basel (Switzerland).
Andrija holds a BSc with honors in Mathematics and a MSc in Computer Science. He completed his PhD studies at Friedrich Miescher Institute for Biomedical Research (affiliated with the Novartis Institutes for Biomedical Research) and earned a PhD (summa cum laude) in Bioinformatics from the University of Basel. Andrija also holds an Executive MBA degree from Swiss Business School, Zürich and is a Certified Financial Analyst (CFA) charterholder, CFA Institute, VA, USA. Andrija has authored ~17 peer-reviewed and highly-cited manuscripts on topics surrounding bioinformatics, machine learning/artificial intelligence/statistics, genomics, clinical genetic studies, and the pharma stock market.
